Drug intelligence / Profile preview

Adsorbed Acellular DTP-IPV-Hib Combined Vaccine

Development stage
Unknown
Lead developer
Beijing Minhai Biological
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Adsorbed Acellular DTP-IPV-Hib Combined Vaccine is a pentavalent combination vaccine developed by Beijing Minhai Biotechnology, a wholly-owned subsidiary of Shenzhen Kangtai Biological Products. The vaccine is designed to induce active immunity against diphtheria, tetanus, pertussis, poliomyelitis, and invasive infections caused by Haemophilus influenzae type b (Hib) in infants and young children. By combining antigens for five major childhood diseases into a single formulation, it significantly reduces the number of required injections, thereby improving compliance and vaccination coverage. The vaccine is currently in Phase 3 clinical development in China.

Other names
DTaP-IPV-Hib vaccineHib-DTP-acellular poliovirus vaccine (Minhai Biological)五联苗五联疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌(结合)联合疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗(五联苗)吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌联合疫苗(五联苗)

Beyond the preview

Go deeper on Adsorbed Acellular DTP-IPV-Hib Combined Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adsorbed Acellular DTP-IPV-Hib Combined Vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call